Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

LRRK2 G2019S Mutation: Prevalence and Clinical Features in Moroccans with Parkinson’s Disease

1 Jan 2017

Abstract excerpt

Background. The LRRK2 G2019S mutation is the most common genetic determinant of Parkinson’s disease (PD) identified to date. This mutation, reported in both familial and sporadic PD, occurs at elevated frequencies in Maghreb population. In the present study, we examined the prevalence of the G2019S mutation in the Moroccan population and we compared the motor and nonmotor phenotype of G2019S carriers to patients...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Botulinum Toxin and Related Neurological Disorders
Share to Neurological diseases and metabolism
Share to Parkinson's Disease Mechanisms and Treatments

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Source

Identifiers

PMID: 28465860
DOI: 10.1155/2017/2412486

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 23 Oct 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

LRRK2 G2019S Mutation: Prevalence and Clinical Features in Moroccans with Parkinson’s DiseasePMID 28465860Read ↗

LRRK2 G2019S Parkinson's disease with more benign phenotype than idiopathic.Semantic proximity Read ↗

Worldwide frequency of G2019S LRRK2 mutation in Parkinson's disease: a systematic review.Semantic proximity Read ↗

G2019S mutation of the leucine-rich repeat kinase 2 gene in a cohort of Egyptian patients with Parkinson's disease.Semantic proximity Read ↗

The Genetic Architecture of Parkinson's Disease in Morocco: Highlighting a Predominance of Mendelian Genes.Semantic proximity Read ↗

Gene Panel Sequencing Analysis Revealed a Strong Contribution of Rare Coding Variants to the Risk of Parkinson's Disease in Sporadic Moroccan Patients.Semantic proximity Read ↗

G2019S LRRK2 mutation in French and North African families with Parkinson's disease.Semantic proximity Read ↗

LRRK2 Gly2019Ser penetrance in Arab-Berber patients from Tunisia: a case-control genetic study.Semantic proximity Read ↗

An overview of the worldwide distribution of LRRK2 mutations in Parkinson's disease.Semantic proximity Read ↗

The p.Gly2019Ser is the commonest pathogenic mutation in the LRRK2 gene among Egyptians with familial and sporadic Parkinson's diseaseSemantic proximity Read ↗

Prevalence of the LRRK2 G2019S mutation in a UK community based idiopathic Parkinson's disease cohort.Semantic proximity Read ↗

Clinical features of Parkinson disease patients with homozygous leucine-rich repeat kinase 2 G2019S mutations.Semantic proximity Read ↗

The G2019S LRRK2 mutation is uncommon in an Asian cohort of Parkinson's disease patients.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.